Werkgroep Cardiologische centra Nederland

ARTESiA (Completed)

A Comparison of Apixaban Versus Aspirin for Preventing Stroke in Patients With Pacemakers (ARTESiA)
Medicine
apixaban
Population
Arrhythmia
Phase
IV
Starting year
2013
More information
ClinicalTrials.gov

Publications: ARTESiA

  • Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation J.S. Healey, R.D. Lopes, C.B. Granger, M. Alings, L. Rivard, W.F. McIntT h e n e w e ngl a nd j o u r na l o f m e dic i n e - Alings, dr. A.M.W. - ARTESiA - Arrhythmia
  • Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trialAm Heart J - Abstract - Alings, dr. A.M.W. - ARTESiA - Arrhythmia

Publications by WCN study

Publications WCN studies by WCN member